Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumors von Dickson, M.A., Okuno, S.H., Keohan, M.L., Maki, R.G., D'Adamo, D.R., Akhurst, T.J., Antonescu, C.R., Schwartz, G.K.

Volltext

High-risk features in radiation-associated breast angiosarcomas von D'Angelo, S P, Antonescu, C R, Kuk, D, Qin, L, Moraco, N, Carvajal, R C, Chi, P, Dickson, M A, Gounder, M, Keohan, M L, Singer, S, Schwartz, G K, Tap, W D

Volltext

Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma von Dickson, M.A., Mahoney, M.R., Tap, W.D., D'Angelo, S.P., Keohan, M.L., Van Tine, B.A., Agulnik, M., Horvath, L.E., Nair, J.S., Schwartz, G.K.

Volltext

Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma von Dickson, Mark A., Keohan, Mary Louise, Crago, A. M., Tap, William D., D’Angelo, S. P., Chi, P., Okoli, C., Schmidt, N., Lala, B., Sanchez, A., Kuk, D., Landa, J., Shoushtari, A. N., Gounder, Mrinal M.

Volltext

A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcoma von Ryan, Christopher W., Matias, Chacon, Agulnik, Mark, Lopez-Pousa, Antonio, Williams, Charles, de Alwis, Dinesh P., Kaiser, Christopher, Miller, Mary Alice, Ermisch, Sabine, Ilaria, Robert, Keohan, M. L.

Volltext

Gemcitabine for relapsed or resistant lymphoma von Savage, D. G., I Rule, S. A., Tighe, M., Garrett, T. J., Oster, W. M., Lee, R. T., Ruiz, J., Heitjan, D., Keohan, M. L., Flamm, M., Johnson, S. A.

Volltext

A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcoma von Talbot, Susan M., Keohan, Mary Louise, Hesdorffer, Mary, Orrico, Russell, Bagiella, Emilia, Troxel, Andrea B., Taub, Robert N.

Volltext

Phenotype of recovering lymphoid cell populations after marrow transplantation von AULT, K. A, ANTIN, J. H, GINSBURG, D, ORKIN, S. H, RAPPEPORT, J. M, KEOHAN, M. L, MARTIN, P, SMITH, B. R

Volltext

Peritoneal mesothelioma von Taub, R N, Keohan, M L, Chabot, J C, Fountain, K S, Plitsas, M

Volltext

A phase II Southwest Oncology Group study of cisplatin and continuous infusion vinblastine in the treatment of advanced soft tissue sarcoma von KEOHAN, M. L, GREVER, M. R, BALCERZAK, S. P, ANTMAN, K

Volltext

A phase II trial of sorafenib (S) and dacarbazine (D) in leiomyosarcoma (LMS), synovial sarcoma (SS), and malignant peripheral nerve sheath tumor (MPNST) von D'Adamo, D. R., Keohan, M. L., Carvajal, R. D., Hensley, M. L., Hirst, C., Qin, L., Antonescu, C., Lefkowitz, R. A., Schwartz, G. K., Maki, R. G.

Volltext

Metastatic epitheloid hemangioendothelioma (EHE): Role of systemic therapy and survival von Cioffi, A., Italiano, A., Penel, N., Berge, Y., Toulmonde, M., Salas, S., Chevreau, C., Le Cesne, A., Duffaud, F., D'Adamo, D. R., Keohan, M. L., Genebes, C., Antonescu, C., Coindre, J., Bui Nguyen, B., Maki, R. G.

Volltext

P16 Loss and Mitotic Activity Predict Poor Survival in Patients with Peritoneal Malignant Mesothelioma von BORCZUK, Alain C, TAUB, Robert N, HESDORFFER, Mary, HIBSHOOSH, Hanina, CHABOT, John A, KEOHAN, Mary L, ALSBERRY, Ritchie, ALEXIS, Diane, POWELL, Charles A

Volltext

Patterns of care, prognosis, and survival of patients with metastatic gastrointestinal stromal tumors (GIST) refractory to first-line imatinib and second-line sunitinib von Italiano, A., Cioffi, A., Maki, R. G., Schoffski, P., Rutkowski, P., Le Cesne, A., Duffaud, F., Adenis, A., Isambert, N., Bompas, E., Blay, J., Casali, P. G., Coco, P., D'Adamo, D. R., Keohan, M. L., Toulmonde, M., Antonescu, C., Debiec-Rychter, M., Coindre, J., Bui Nguyen, B.

Volltext

Phase II study of temozolomide and thalidomide in patients with unresectable or metastatic leiomyosarcoma von Boyar, M., Keohan, M. L., Hesdorffer, M., Taub, R.

Volltext

Combined heart and lung transplantation for unresectable primary cardiac sarcoma von Talbot, Susan M., Taub, Robert N., Keohan, Mary Lou, Edwards, Niloo, Galantowicz, Mark E., Schulman, Larry L.

Volltext

Updated results of a phase II study of oral multi-kinase inhibitor sorafenib in sarcomas, CTEP study #7060 von Maki, R. G., Keohan, M. L., Undevia, S. D., Livingston, M., Cooney, M. M., Elias, A., Saulle, M. F., Wright, J. J., D’Adamo, D. R., Schuetze, S. M.

Volltext

Early metabolic response to continuous daily dosing of sunitinib in soft tissue sarcomas (STS) other than GIST using FDG- PET von Van den Abbeele, A. D., Yap, J. T., Rastarhuyeva, I., Akhurst, T., Keohan, M. L., George, S., Bhuchar, G., Morgan, J. A., Demetri, G. D., Maki, R. G.

Volltext

Continuous daily dosing (CDD) of sunitinib (SU) in patients with metastatic soft tissue sarcomas (STS) other than GIST: Results of a phase II trial von Keohan, M. L., Morgan, J. A., D’Adamo, D. R., Harmon, D., Butrynski, J. E., Wagner, A. J., Schwartz, G. K., Maki, R. G., Demetri, G. D., George, S.

Volltext

Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma von Hesdorffer, Mary E, Chabot, John A, Keohan, Mary Louise, Fountain, Karen, Talbot, Susan, Gabay, Michelle, Valentin, Catherine, Lee, Shing M, Taub, Robert N

Volltext